Katalin Kariko and Drew Weissman win the Nobel Prize in Medicine

The Nobel Prize for Medicine has been awarded to Katalin Kariko and Drew Weissman, two researchers from the University of Pennsylvania, for their major contribution to the creation of the messenger RNA vaccine. This distinction marks a break with tradition by rewarding contemporary scientists, and underlines the importance of their work in the context of the Covid-19 pandemic.

Pfizer/BioNTech and Moderna's messenger RNA vaccines have revolutionised the world of medical research and healthcare in general. In record time, these new vaccines have surpassed all previous technologies, offering rapid and effective immunisation against the virus. Their 95% efficacy against the initial strain of Covid-19 places them at the forefront of available vaccine solutions.

The work of Katalin Kariko and Drew Weissman was essential to the development of this innovative technology. Their contribution overcame the obstacles associated with the use of messenger RNA, paving the way for the creation of safe and effective vaccines. Thanks to their pioneering research, billions of doses of messenger RNA vaccines have been administered worldwide, helping to save many lives and mitigate the devastating impact of the pandemic.

This Nobel Prize highlights the crucial role of scientific research in the fight against infectious diseases. It also highlights the importance of international collaboration and innovation in tackling global health challenges.

Katalin Kariko and Drew Weissman join the prestigious circle of Nobel Prize winners in medicine, and their work will continue to inspire the next generation of researchers in the quest for innovative medical solutions.